Cargando…

HLA genotyping in Japanese patients with multiple myeloma receiving bortezomib: An exploratory biomarker study of JCOG1105 (JCOG1105A1)

Bortezomib (Btz) shows robust efficacy in patients with multiple myeloma (MM); however, some patients experience suboptimal responses and show specific toxicities. Therefore, we attempted to identify specific HLA alleles associated with Btz‐related toxicities and response to treatment. Eighty‐two tr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ri, Masaki, Iida, Shinsuke, Maruyama, Dai, Sakabe, Aya, Kamei, Ryo, Nakashima, Takuto, Tohkin, Masahiro, Osaga, Satoshi, Tobinai, Kensei, Fukuhara, Noriko, Miyazaki, Kana, Tsukamoto, Norifumi, Tsujimura, Hideki, Yoshimitsu, Makoto, Miyamoto, Kenichi, Tsukasaki, Kunihiro, Nagai, Hirokazu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645746/ https://www.ncbi.nlm.nih.gov/pubmed/34626515 http://dx.doi.org/10.1111/cas.15158

Ejemplares similares

Randomised phase II study to optimise melphalan, prednisolone, and bortezomib in untreated multiple myeloma (JCOG1105)
por: Maruyama, Dai, et al.
Publicado: (2020)

Final analysis of randomized phase II study optimizing melphalan, prednisolone, bortezomib in multiple myeloma (JCOG1105)
por: Maruyama, Dai, et al.
Publicado: (2022)

Single response assessment of transplant-ineligible multiple myeloma: a supplementary analysis of JCOG1105 (JCOG1105S1)
por: Nakamura, Nobuhiko, et al.
Publicado: (2021)

R‐High‐CHOP/CHASER/LEED with autologous stem cell transplantation in newly diagnosed mantle cell lymphoma: JCOG0406 STUDY
por: Ogura, Michinori, et al.
Publicado: (2018)

1105 Chronic Kidney Disease and Invasive Pneumococcal Disease in Adults
por: Baxter, Roger, et al.
Publicado: (2014)

Improving properties of the nucleobase analogs T-705/T-1105 as potential antiviral
por: Jia, Xiao, et al.
Publicado: (2021)

Long‐term follow‐up after R‐High CHOP/CHASER/LEED with Auto‐PBSCT in untreated mantle cell lymphoma—Final analysis of JCOG0406
por: Ogura, Michinori, et al.
Publicado: (2023)

Tuberculosis in Takayasu arteritis: a retrospective study in 1105 Chinese patients
por: Zhang, Ying, et al.
Publicado: (2019)

Genomic landscape and its prognostic significance in stage III colorectal cancer: JCOG1506A1, an ancillary of JCOG0910
por: Shida, Dai, et al.
Publicado: (2023)

Viral polymerase inhibitors T-705 and T-1105 are potential inhibitors of Zika virus replication
por: Cai, Lei, et al.
Publicado: (2017)

1105. Population Pharmacokinetic Analyses for Tebipenem After the Administration of Tebipenem Pivoxil Hydrobromide
por: Ganesan, Harish, et al.
Publicado: (2021)

R‐CHOP‐14 versus R‐CHOP‐14/CHASER for upfront autologous transplantation in diffuse large B‐cell lymphoma: JCOG0908 study
por: Kagami, Yoshitoyo, et al.
Publicado: (2020)

Draft genome sequence of Wickerhamomyces anomalus LBCM1105, isolated from cachaça fermentation
por: Cunha, Aureliano C., et al.
Publicado: (2020)

P1105: NEUROLOGIC INVOLVEMENT IN ADULTS WITH ROSAI-DORFMAN DISEASE: CLINICAL PRESENTATION AND OUTCOMES
por: Acosta Medina, Aldo, et al.
Publicado: (2023)

Clinical characteristics of patients with B-cell lymphoma enrolled in clinical trials for aggressive lymphoma in Japan: Japan Clinical Oncology Group - Lymphoma Study Group study – JCOG0108A
por: Kinoshita, Tomohiro, et al.
Publicado: (2021)

(1105) Multisystem Inflammatory Syndrome in a Pediatric Heart Transplant Recipient: A Case Report
por: Shibbani, K., et al.
Publicado: (2023)

1105. Vibriocidal Titer Variation and Likelihood of Protection in Children Compared With Adults in a Cholera Endemic Area
por: Ritter, Alaina, et al.
Publicado: (2018)

1105. Statewide, Retrospective, Cohort Study of Medicare Part B Quinolone Prescribing for Cystitis in 2016–2017
por: Yu, Joyce, et al.
Publicado: (2019)

Bortezomib plus dexamethasone vs thalidomide plus dexamethasone for relapsed or refractory multiple myeloma
por: Iida, Shinsuke, et al.
Publicado: (2018)

ACT-25 CLINICAL TRIALS BY THE JCOG BRAIN TUMOR STUDY GROUP
por: Nishikawa, Ryo
Publicado: (2019)

Geriatric Research Policy: Japan Clinical Oncology Group (JCOG) policy
por: Mizutani, Tomonori, et al.
Publicado: (2019)

A single-arm confirmatory trial of pazopanib in patients with paclitaxel-pretreated primary cutaneous angiosarcoma: Japan Clinical Oncology Group study (JCOG1605, JCOG-PCAS protocol)
por: Oashi, Kohei, et al.
Publicado: (2020)

Second primary malignancies in patients with clinical T1bN0 esophageal squamous cell carcinoma after definitive therapies: supplementary analysis of the JCOG trial: JCOG0502
por: Mitani, Seiichiro, et al.
Publicado: (2022)

P1220: CHARACTERISTICS OF SECONDARY CENTRAL NERVOUS SYSTEM INVOLVEMENT IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA – A SUPPLEMENTARY ANALYSIS OF JCOG0601
por: Shimada, K., et al.
Publicado: (2022)

Clinical Trials and Treatment of ATL
por: Tsukasaki, Kunihiro, et al.
Publicado: (2012)

Usefulness of an S-1 dosage formula: an exploratory analysis of randomized clinical trial (JCOG1001)
por: Kawakami, Takeshi, et al.
Publicado: (2022)

Molecular Testing for Fragile X: Analysis of 5062 Tests from 1105 Fragile X Families—Performed in 12 Clinical Laboratories in Spain
por: Tejada, María-Isabel, et al.
Publicado: (2014)

1105. The Burden of Infections Prior to Chimeric Antigen Receptor (CAR) Modified T-cell Therapy Predicts Post-CAR T-cell Infectious Complications
por: Garner, Will, et al.
Publicado: (2020)

Evolving of treatment paradigms and challenges in acute promyelocytic leukaemia: A real-world analysis of 1105 patients over the last three decades
por: Teng-Fei, Sun, et al.
Publicado: (2022)

SG-APSIC1105: The effectiveness of the infection control interventions in decreasing multidrug-resistant organism transmission in the Department of Neonatology of Hung Vuong Hospital
por: Nhung, Ngo, et al.
Publicado: (2023)

Addenda and corrigenda: Juřena D (2022) A critical review of the distribution of the endangered European earth-borer beetle Bolbelasmusunicornis (Coleoptera, Geotrupidae), with new records from 13 countries and observations on its bionomy. ZooKeys 1105: 1–125. https://doi.org/10.3897/zookeys.1105.81474
por: Juřena, Daniel
Publicado: (2023)

A randomised trial of intrapericardial bleomycin for malignant pericardial effusion with lung cancer (JCOG9811)
por: Kunitoh, H, et al.
Publicado: (2009)

Birth Prevalence of Homocystinuria in Central Europe: Frequency and Pathogenicity of Mutation c.1105C>T (p.R369C) in the Cystathionine Beta-Synthase Gene
por: Janošík, Miroslav, et al.
Publicado: (2009)

A Novel Homozygous p.R1105X Mutation of the AP4E1 Gene in Twins with Hereditary Spastic Paraplegia and Mycobacterial Disease
por: Kong, Xiao-Fei, et al.
Publicado: (2013)

Serum lipidomics for exploring biomarkers of bortezomib therapy in patients with multiple myeloma
por: Maekawa, Keiko, et al.
Publicado: (2019)

Patient-reported outcome and quality of life research policy: Japan Clinical Oncology Group (JCOG) policy
por: Ishiki, Hiroto, et al.
Publicado: (2023)

Clinical outcome of primary giant cell tumor of bone after curettage with or without perioperative denosumab in Japan: from a questionnaire for JCOG 1610 study
por: Urakawa, Hiroshi, et al.
Publicado: (2018)

Phase I/II trial of weekly cisplatin, etoposide, and irinotecan chemotherapy for metastatic lung cancer: JCOG 9507
por: Sekine, I, et al.
Publicado: (2003)

Comparison of gemcitabine-based chemotherapies for advanced biliary tract cancers by renal function: an exploratory analysis of JCOG1113
por: Ueno, Makoto, et al.
Publicado: (2021)

The clinical outcomes of combination chemotherapy in elderly patients with advanced biliary tract cancer: an exploratory analysis of JCOG1113
por: Yamada, Ikuhiro, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_imrhl6duhm2ocmqvpgpqa0dh62